Title : Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure.

Pub. Date : 2015 Apr 13

PMID : 25867530






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. Simendan myeloperoxidase Homo sapiens
2 We evaluated the effects of levosimendan-treatment on MPO in patients with acute decompensation of chronic heart failure over a one week course. Simendan myeloperoxidase Homo sapiens
3 Plasma MPO levels were significantly decreased after levosimendan treatment (from 252.1 +- 31.1 pmol/l at baseline to 215.02 +- 27.96 pmol/l at 6 h, p < 0.05). Simendan myeloperoxidase Homo sapiens
4 Ex vivo incubation of whole blood with levosimendan decreased MPO release after PMN-stimulation (8.2 +- 1.4-fold increase at baseline vs. 6.0 +- 1.1-fold increase with levosimendan). Simendan myeloperoxidase Homo sapiens
5 We here provide the first evidence that levosimendan treatment inhibits MPO release by PMNs in decompensated heart failure patients. Simendan myeloperoxidase Homo sapiens